ArticleBMC endocrine disorders2025
Association of medication adherence and glycemic control with pain severity among patients with diabetes mellitus: a cross-sectional study from Palestine.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe evaluation of pain and medication compliance in patients with type 2 diabetes mellitus is essential for efficient illness management. This study aimed to assess the associations of medication adherence and glycemic control with pain severity among patients with diabetes mellitus.
methodsThis study was conducted with a cross-sectional design. The study used the Arabic versions of the Brief Pain Inventory Scale and the Medication Adherence Rating Scale. The patients were included from different healthcare centers in Nablus city. The data were collected via a structured questionnaire.
resultsIn this study, 377 patients were included. Of those, 244 (64.7%) were female. The median age of the patients was 62 [IQR: 55.5, 68.0] years. The median time since the diagnosis of type 2 diabetes mellitus was 8 [IQR: 4.0, 15.0] years, and the HbA1c level was 7.8% [IQR: 6.8%, 9.0%]. Among the patients, 162 (43.0%) had no pain, 92 (24.4%) had mild pain, 43 (11.4%) had moderate pain, and 80 (21.2%) had severe pain. The median adherence score was 8.0 [7.0, 9.0]. In the multivariable analysis, pain severity was significantly associated with factors such as not having a formal education (B = − 0.21, p = 0.007), ankle pain (B = -1.01, p < 0.001), orphenadrine use (B = − 2.08, p = 0.005) and higher pain interference scores (B = 0.45, p < 0.001). For medication adherence, significant predictors included older age (B = 0.01, p = 0.038), the use of glimepiride (B = − 0.34, p = 0.009), and the use of duloxetine (B = 1.21, p = 0.022). No significant association was found between medication adherence and pain severity (p = 0.617).
conclusionsPain severity was most strongly associated with pain interference, educational level, ankle pain, and the use of orphenadrine. Medication adherence was significantly predicted by older age, the use of glimepiride, and the use of duloxetine. These findings highlight key factors influencing pain and adherence among patients with diabetes mellitus.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.